This new volume of *Advances in Pharmacology* explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essentia
[Advances in Pharmacology] Antiviral Agents Volume 67 || Hepatitis C Virus
β Scribed by Pawlotsky, Jean-Michel
- Book ID
- 121234512
- Publisher
- Elsevier
- Year
- 2013
- Tongue
- English
- Weight
- 488 KB
- Edition
- 1
- Category
- Article
- ISBN
- 0124058809
- ISSN
- 1054-3589
No coin nor oath required. For personal study only.
β¦ Synopsis
This new volume of Advances in Pharmacology explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.
- Explores the current state of anti-viral agents
- Chapters cover a variety of topics such as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV
- With the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike
π SIMILAR VOLUMES
This new volume of *Advances in Pharmacology* explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essentia
This new volume of *Advances in Pharmacology* explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essentia
A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combinati
A crucial issue for antiviral therapy is the fact that all antiviral substances rapidly select for resistance; thus, monitoring and overcoming resistance has become a most important clinical paradigm of antiviral therapy. This calls for cautious use of antiviral drugs and implementation of combinati
Vitamin D supplementation was reported to improve the probability of achieving a sustained virological response when combined with antiviral treatment against hepatitis C virus (HCV). Our aim was to determine the in vitro potential of vitamin D to inhibit HCV infectious virus production and explore